We used consensus to resolve discrepancies ... The following comparisons were direct (figure 2): ASA versus ASA plus clopidogrel, ASA versus control, ASA plus clopidogrel versus VKA, VKA versus ...
The Annals of Pharmacotherapy. 2008;42(6):790-805.
Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback